Tenon Medical (TNON) reported second-quarter 2026 revenue of $1.3 million, up 127% from $0.6 million a year earlier. Net loss was $4.1 million, or $12.35 per share, compared with a $2.8 million loss, or $12.76 per share, in the prior-year quarter.
Gross profit rose 232% to $0.8 million, while gross margin increased to 64% from 43%. The company also reported FDA 510(k) clearance for its updated Catamaran SI Joint Fusion System and closed a $4.2 million public offering after quarter-end.
- Revenue was $1.279 million for the three months ended June 30, 2026.
- Gross profit was $0.814 million, compared with $0.245 million a year earlier.
- Cash and cash equivalents totaled $1.7 million as of June 30, 2026.
- July 2026 marked the company’s highest monthly surgical case volume to date.
- Tenon completed a 1-for-35 reverse stock split on August 10, 2026.
$TNONW Hedge Fund Activity
We have seen 7 institutional investors add shares of $TNONW stock to their portfolio, and 2 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FOCUS PARTNERS WEALTH added 4,658,113 shares (+7526.8%) to their portfolio in Q2 2026, for an estimated $50,307
- AQR CAPITAL MANAGEMENT LLC added 131,000 shares (+inf%) to their portfolio in Q1 2026, for an estimated $1,048
- VIRTU FINANCIAL LLC removed 14,651 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $117
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 11,710 shares (+inf%) to their portfolio in Q1 2026, for an estimated $93
- HRT FINANCIAL LP added 10,078 shares (+inf%) to their portfolio in Q1 2026, for an estimated $80
- CITADEL ADVISORS LLC added 1,188 shares (+1.7%) to their portfolio in Q1 2026, for an estimated $9
- UBS GROUP AG added 399 shares (+399.0%) to their portfolio in Q2 2026, for an estimated $4
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
